News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
224,347 Results
Type
Article (18451)
Company Profile (153)
Press Release (205743)
Multimedia
Podcasts (32)
Webinars (3)
Section
Business (61780)
Career Advice (197)
Deals (9000)
Drug Delivery (59)
Drug Development (33992)
Employer Resources (33)
FDA (6765)
Job Trends (6255)
News (112229)
Policy (11350)
Tag
Academia (1585)
Academic (1)
Accelerated approval (5)
Adcomms (11)
Allergies (44)
Alliances (17795)
ALS (46)
Alzheimer's disease (592)
Antibody-drug conjugate (ADC) (46)
Approvals (6824)
Artificial intelligence (137)
Autoimmune disease (11)
Automation (7)
Bankruptcy (55)
Best Places to Work (5991)
BIOSECURE Act (7)
Biosimilars (61)
Biotechnology (112)
Bladder cancer (44)
Brain cancer (13)
Breast cancer (147)
Cancer (1149)
Cardiovascular disease (113)
Career advice (176)
Career pathing (7)
CAR-T (84)
Cell therapy (238)
Cervical cancer (9)
Clinical research (28434)
Collaboration (482)
Compensation (205)
Complete response letters (8)
COVID-19 (1082)
CRISPR (35)
C-suite (143)
Cystic fibrosis (61)
Data (1378)
Decentralized trials (1)
Denatured (16)
Depression (18)
Diabetes (159)
Diagnostics (2234)
Digital health (9)
Diversity (6)
Diversity, equity & inclusion (12)
Drug discovery (73)
Drug pricing (68)
Drug shortages (17)
Duchenne muscular dystrophy (64)
Earnings (19230)
Editorial (14)
Employer branding (2)
Employer resources (31)
Events (33440)
Executive appointments (383)
FDA (7502)
Friedreich's ataxia (1)
Frontotemporal dementia (7)
Funding (327)
Gene editing (81)
Generative AI (14)
Gene therapy (200)
GLP-1 (410)
Government (1609)
Grass and pollen (1)
Guidances (76)
Healthcare (7647)
Huntington's disease (11)
IgA nephropathy (18)
Immunology and inflammation (53)
Indications (21)
Infectious disease (1160)
Inflammatory bowel disease (100)
Inflation Reduction Act (5)
Influenza (28)
Intellectual property (40)
Interviews (14)
IPO (4343)
IRA (21)
Job creations (722)
Job search strategy (167)
Kidney cancer (7)
Labor market (9)
Layoffs (132)
Leadership (2)
Legal (1799)
Liver cancer (31)
Lung cancer (171)
Lymphoma (105)
Machine learning (3)
Management (10)
Manufacturing (158)
MASH (51)
Medical device (2579)
Medtech (2580)
Mergers & acquisitions (4888)
Metabolic disorders (422)
Multiple sclerosis (39)
NASH (12)
Neurodegenerative disease (41)
Neuropsychiatric disorders (11)
Neuroscience (876)
NextGen: Class of 2025 (2128)
Non-profit (1699)
Now hiring (8)
Obesity (229)
Opinion (74)
Ovarian cancer (43)
Pain (55)
Pancreatic cancer (29)
Parkinson's disease (66)
Partnered (11)
Patents (89)
Patient recruitment (53)
Peanut (23)
People (22403)
Pharmaceutical (34)
Pharmacy benefit managers (10)
Phase I (7898)
Phase II (11509)
Phase III (11129)
Pipeline (713)
Policy (74)
Postmarket research (1436)
Preclinical (3127)
Press Release (15)
Prostate cancer (56)
Psychedelics (9)
Radiopharmaceuticals (144)
Rare diseases (233)
Real estate (1539)
Recruiting (9)
Regulatory (9069)
Reports (13)
Research institute (1349)
Resumes & cover letters (17)
Rett syndrome (5)
RNA editing (4)
RSV (19)
Schizophrenia (40)
Series A (68)
Series B (50)
Service/supplier (1)
Sickle cell disease (42)
Special edition (6)
Spinal muscular atrophy (84)
Sponsored (11)
Startups (1361)
Stomach cancer (6)
Supply chain (35)
Tariffs (35)
The Weekly (15)
Vaccines (290)
Venture capitalists (17)
Weight loss (136)
Women's health (15)
Worklife (1)
Date
Today (113)
Last 7 days (436)
Last 30 days (1572)
Last 365 days (14706)
2025 (5638)
2024 (15469)
2023 (16756)
2022 (20916)
2021 (21715)
2020 (19862)
2019 (17099)
2018 (12827)
2017 (12034)
2016 (11194)
2015 (12066)
2014 (8450)
2013 (6941)
2012 (7035)
2011 (6999)
2010 (5670)
Location
Africa (236)
Alabama (26)
Alaska (1)
Arizona (45)
Arkansas (3)
Asia (15092)
Australia (2096)
California (2853)
Canada (690)
China (277)
Colorado (86)
Connecticut (146)
Delaware (110)
Europe (33802)
Florida (404)
Georgia (73)
Idaho (14)
Illinois (243)
India (16)
Indiana (190)
Iowa (3)
Japan (129)
Kansas (40)
Kentucky (7)
Louisiana (5)
Maine (26)
Maryland (304)
Massachusetts (2424)
Michigan (35)
Minnesota (79)
Mississippi (1)
Missouri (40)
Montana (7)
Nebraska (4)
Nevada (16)
New Hampshire (10)
New Jersey (1027)
New Mexico (10)
New York (831)
North Carolina (458)
North Dakota (5)
Northern California (1357)
Ohio (83)
Oklahoma (4)
Oregon (18)
Pennsylvania (599)
Puerto Rico (1)
Rhode Island (11)
South America (297)
South Carolina (3)
Southern California (1027)
Tennessee (24)
Texas (304)
United States (10703)
Utah (97)
Virginia (72)
Washington D.C. (36)
Washington State (277)
Wisconsin (28)
224,347 Results for "totus medicines".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Totus Medicines to Present at 42nd Annual J.P. Morgan Healthcare Conference
Totus Medicines announced today today announced that Totus President and CEO, Nassim Usman , Ph.D., will be presenting a corporate update at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco.
January 2, 2024
·
1 min read
Business
Totus Medicines Appoints John Maraganore to Scientific Advisory Board
Totus Medicines, the drug discovery and development company revolutionizing small molecule drugs to end the era of untreatable disease, is pleased to announce the appointment of John Maraganore, Ph.D., to the company’s Scientific Advisory Board.
October 19, 2023
·
3 min read
Press Releases
Totus Medicines Announces Successful Completion of a Phase 1 Dose-Escalation Study and Initiation of an Expansion Trial Evaluating TOS-358, a Covalent PI3Ka Selective Therapy for the Treatment of Select Solid Tumors and Appoints Zelanna Goldberg as Chief Medical Officer
January 10, 2025
·
3 min read
Biotech Bay
Totus Medicines CEO to Chair Next-Generation Undruggable and Present at Future of R&D Week 2023
Totus Medicines today announced its participation at this year’s Future of R&D Week in Boston from October 3-5.
September 27, 2023
·
2 min read
Business
Totus Medicines Announces Appointment of Nassim Usman, Ph.D., as President & CEO and the Closing of a $66M Series B Funding
Totus Medicines, a company revolutionizing small molecule drug discovery and development using covalent libraries and AI tools, announced that Nassim Usman, Ph.D., has been named President & Chief Executive Officer and closed a $66M Series B financing led by DCVC Bio.
December 15, 2023
·
3 min read
Biotech Bay
Totus Medicines Announces Presentations at the Upcoming American Association for Cancer Research (AACR) Annual Meeting
Totus Medicines announced it will be presenting four posters at the American Association for Cancer Research (AACR) Annual Meeting, regarding its lead program, TOS-358, the first highly specific, covalent PI3Kα inhibitor.
April 10, 2023
·
4 min read
Drug Development
Totus Medicines Announces First Patient Dosed in Phase 1 Trial of TOS-358 for the Treatment Of Select Solid Tumors
Totus Medicines announced today the dosing of the first patient in a Phase 1 clinical trial of TOS-358, the company’s first-in-class covalent PI3Kα inhibitor for the treatment of numerous cancers with known PIK3CA mutations.
April 13, 2023
·
2 min read
Business
Totus Medicines Hires Corporate Strategy Leader Laura Miller
Totus Medicines today announced the hiring of Laura Miller as the company’s first Chief Business Officer (CBO)/Chief Operating Officer (COO).
March 23, 2022
·
2 min read
Obesity
WHO Leaning Toward Adding Obesity Drugs for Adults to Essential Medicines List:
Reuters
In an internal memo, the World Health Organization signaled its support for anti-obesity drugs like Wegovy and Zepbound, which the agency decided against listing in 2023, the last time the Essential Medicines list was updated.
May 2, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Scipher Medicine and InnoSIGN Announce Partnership to Advance Precision Medicine in Immunology
April 30, 2025
·
3 min read
1 of 22,435
Next
